pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$GOSSGossamer Bio, Inc.

$GOSS
San Diego, CA, USupdated 15d ago
Website ↗SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
1
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0

Pipeline(1)

pipeline depth1 products
Phase 3: 1
1Phase 3
Phase 3
seralutinib
Pulmonary Arterial Hypertension
Platelet-derived growth factor receptorMacrophage colony-stimulating factor 1 receptor

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Insider activity

source: SEC Form 4
routine RSU / option mechanics (6)
  • Mar 19, 26dispo to issuerAranda Richard · Chief Medical Officer572,000 sh
  • Mar 19, 26dispo to issuerAranda Richard · Chief Medical Officer487,500 sh
  • Mar 19, 26dispo to issuerAranda Richard · Chief Medical Officer162,500 sh
  • Mar 19, 26dispo to issuerAranda Richard · Chief Medical Officer157,500 sh
  • Mar 19, 26dispo to issuerAranda Richard · Chief Medical Officer157,500 sh
  • Mar 19, 26dispo to issuerAranda Richard · Chief Medical Officer126,667 sh
🐶 Hiring Signal
No open roles indexed yet — view Gossamer Bio, Inc. jobs →

News

  • Two biotechs sign reverse mergers to advance I&I drug, BTK inhibitor
    A biotech with a bispecific antibody from China and a little-known San Diego startup with a BTK inhibitor from Gossamer Bio have each signed reverse mergers to take their experimental medicines ont…
    endpoints · 16d ago
  • A neglected issue in pedestrian, biker deaths
    Fauci's testimony, visa time limits for research students, and more health news from Morning Rounds
    stat · 16d ago
  • Visa time limits on foreign Ph.D. students and postdocs will harm U.S. science, experts warn
    A Trump administration plan to limit visas for graduate student and postdocs to four years is fueling concerns that the U.S. could lose out on foreign scientists
    stat · 17d ago
  • Yarrow to begin trading as it targets Graves; FDA approves Otsuka's ADHD pill
    Plus news about Outlook Therapeutics, Gossamer Bio, Apnimed and Entera Bio. 📈 Yarrow closes merger to go public: Yarrow Bioscience is developing an anti-TSHR antibody for Graves’ disease and thyro…
    endpoints · 18d ago
  • Opinion: Why STAT is sticking with ‘health care’ as two words
    Is it “health care” or “healthcare”? STAT readers had strong feelings.
    stat · 2mo ago
identifiers
ticker
$GOSS
SEC CIK
0001728117
country
US
source
sec_tickers
top tags
Cardiology1
mentioned in
5news items
entity-linker matched
Data sources
SEC EDGAR
last refreshed 1m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?